Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 2
1983 1
1985 1
1987 1
1988 4
1989 1
1990 3
1991 1
1992 1
1993 3
1994 4
1995 4
1997 2
1998 2
1999 2
2000 2
2001 4
2002 3
2003 2
2004 3
2005 1
2006 3
2007 6
2008 3
2009 3
2010 1
2011 4
2012 8
2013 8
2014 8
2015 4
2016 6
2017 4
2018 4
2019 2
2020 5
2021 2
2022 1
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
Role of metallothionein in carcinogenesis.
Cherian MG, Howell SB, Imura N, Klaassen CD, Koropatnick J, Lazo JS, Waalkes MP. Cherian MG, et al. Among authors: koropatnick j. Toxicol Appl Pharmacol. 1994 May;126(1):1-5. doi: 10.1006/taap.1994.1083. Toxicol Appl Pharmacol. 1994. PMID: 8184419 Review.
Toxicology of antisense therapeutics.
Jason TL, Koropatnick J, Berg RW. Jason TL, et al. Among authors: koropatnick j. Toxicol Appl Pharmacol. 2004 Nov 15;201(1):66-83. doi: 10.1016/j.taap.2004.04.017. Toxicol Appl Pharmacol. 2004. PMID: 15519609 Review.
Signaling events for metallothionein induction.
Haq F, Mahoney M, Koropatnick J. Haq F, et al. Among authors: koropatnick j. Mutat Res. 2003 Dec 10;533(1-2):211-26. doi: 10.1016/j.mrfmmm.2003.07.014. Mutat Res. 2003. PMID: 14643422 Review.
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
Wagner SC, Markosian B, Ajili N, Dolan BR, Kim AJ, Alexandrescu DT, Dasanu CA, Minev B, Koropatnick J, Marincola FM, Riordan NH. Wagner SC, et al. Among authors: koropatnick j. J Transl Med. 2014 May 13;12:127. doi: 10.1186/1479-5876-12-127. J Transl Med. 2014. PMID: 24884532 Free PMC article. Review.
Antisense treatment in human prostate cancer and melanoma.
Di Cresce C, Koropatnick J. Di Cresce C, et al. Among authors: koropatnick j. Curr Cancer Drug Targets. 2010 Sep;10(6):555-65. doi: 10.2174/156800910791859452. Curr Cancer Drug Targets. 2010. PMID: 20482488 Review.
From Solo in the Silo to Strategic Training Programs.
Koritzinsky M, Koch CA, Riley B, Beauchemin N, Johnston G, Johnston M, Koropatnick J, Loiselle CG, Maslowska M, McCormick C, Miller WH Jr, Mulligan L, Tsao MS. Koritzinsky M, et al. Among authors: koropatnick j. CBE Life Sci Educ. 2016 Spring;15(1):le1. doi: 10.1187/cbe.15-03-0076. CBE Life Sci Educ. 2016. PMID: 27290740 Free PMC article. No abstract available.
TdIF1: a putative oncogene in NSCLC tumor progression.
Zhang Y, Wang Z, Huang Y, Ying M, Wang Y, Xiong J, Liu Q, Cao F, Joshi R, Liu Y, Xu D, Zhang M, Yuan K, Zhou N, Koropatnick J, Min W. Zhang Y, et al. Among authors: koropatnick j. Signal Transduct Target Ther. 2018 Oct 19;3:28. doi: 10.1038/s41392-018-0030-9. eCollection 2018. Signal Transduct Target Ther. 2018. PMID: 30345081 Free PMC article.
Reduction of tumorigenicity by placental extracts.
Marleau AM, McDonald G, Koropatnick J, Chen CS, Koos D. Marleau AM, et al. Among authors: koropatnick j. Anticancer Res. 2012 Apr;32(4):1153-61. Anticancer Res. 2012. PMID: 22493344
110 results